CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (PARENTHETICAL) $ in Millions	9 Months Ended
	Sep. 29, 2019 USD ($)
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	$ 8,233	[1]
GSK Consumer Healthcare [Member]
Equity method investment, ownership percentage	32.00%
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	$ 8,200
Fair value of equity method investment	15,700
Net assets contributed	7,600
Cash conveyed	$ 146

[1] The $8.2 billion Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed for the nine months ended September 29, 2019 reflects the receipt of a 32% equity-method investment in the new company valued at $15.7 billion in exchange for net assets contributed of $7.6 billion and is presented in operating activities net of $146 million cash conveyed that is reflected in Other investing activities, net. See Note 2B.See Notes to Condensed Consolidated Financial Statements.